PRESS-RELEASE ·Filed Apr 30, 2026

MEOH

Methanex Corporation
BEARISH
Impact 7/10
Horizonweeks Processed5mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight ▼ Bearish

The 28.6% EPS miss and prior quarter's severe miss suggest deteriorating fundamentals. Watch for the next quarterly report (Jun 2026) to see if the company can meet the elevated $1.73 consensus; a further miss would likely pressure the stock further.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
MEOH ▼ -17.20% at T+60d
SHORT call ✓ call won +17.20% · α vs SPY +20.27% · entry $64.25 → $53.20
Entry anchored
Apr 30, 2026
via day open
T+1d
+0.95%
call -0.95% · α -1.29%
$64.86
settled 5mo ago
T+5d
-6.32%
call +6.32% · α +8.67%
$60.19
settled 5mo ago
T+20d
-4.81%
call +4.81% · α +10.08%
$61.16
settled 4mo ago
T+60d
-17.20%
call +17.20% · α +20.27%
$53.20
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Methanex reported Q1 2026 EPS of $0.30, a 28.6% miss versus the $0.42 consensus, with no revenue figure provided in the filing. The miss extends a pattern of earnings volatility and follows a prior quarter's large miss, reinforcing a bearish near-term outlook.

Key Financial Metrics

EPS
$0.30
est $0.42 · -28.6%
Rating
miss

Key Facts

  • Q1 2026 EPS of $0.30 missed consensus of $0.42 by 28.6%
  • No revenue figure disclosed in this filing
  • Prior quarter (Dec 2025) EPS was -$0.14 vs consensus $0.84, a 116.7% miss
  • Next-quarter Street consensus is $1.73, implying a wide range of outcomes ($0.58-$3.71)
  • Annual general meeting results show strong shareholder support for directors and executive compensation

Financial Impact

EPS miss of $0.12 per share vs consensus

eps

Risk Factors

  • Continued earnings volatility and inability to meet consensus estimates
  • Wide analyst range for next quarter ($0.58-$3.71) signals high uncertainty
  • Potential for further downward revisions to guidance

Market Snapshot

Exchange
Nasdaq
Sector
Industrial Organic Chemicals
Analyst Consensus
77% bullish (13 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3285577
9 reports for MEOH
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+5▲ +5.05%Jun 29, 2026
Filters
Rows
Reports for MEOH — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
Press Release
BEARISH ★ 6/10
$60.57 $58.68▲ +3.12%▲ +2.79%$58.74 (+3.03%)
Jul 28, 2026
9w ago
Press Release
BEARISH ★ 7/10
$54.64 $56.93▼ −4.19%▲ +0.83%$58.74 (−7.49%)
Jun 29, 2026
13w ago
6-K
BEARISH ★ 6/10
$46.15 $54.18▼ −17.40%▼ −18.43%$58.74 (−27.27%)
May 1, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$64.25 $61.16▼ −4.81%▼ −10.09%$58.74 (−8.58%)
Apr 30, 2026
22w ago
Press Release
BEARISH ★ 7/10
$64.25 $61.16▲ +4.81%▲ +10.08%$58.74 (+8.58%)
Apr 29, 2026
22w ago
Press Release
NEUTRAL ★ 2/10
$65.54 $59.10▼ −9.83%▼ −15.05%$58.74 (−10.38%)
Apr 29, 2026
22w ago
6-K
MIXED ★ 6/10
$65.54 $59.83▼ −8.71%▼ −13.68%$58.74 (−10.38%)
Apr 20, 2026
23w ago
144
NEUTRAL ★ 4/10
$58.37 $62.09▲ +6.37%▲ +1.46%$58.74 (+0.63%)
Mar 5, 2026
30w ago
Press Release
BEARISH ★ 6/10
$49.65 $61.57▼ −24.01%▼ −26.06%$58.74 (−18.30%)
Showing 9 of 9

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 30, 2026